EPO and Nijmegen breakage syndrome: Among signaling pathways with the highest association with metastatic NBs and NBs with poor response to the therapy were growth factor signaling pathways: erythropoietin (EPO), neural growth factor (NGF), and hepatocyte growth factor (HGF) (Fig. 2b, Table S5).